An fMRI Study Of Brain Response In Patients With Fibromyalgia
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by
evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance
imaging) is an efficient way to show whether new pain medications are effective in treating
fibromyalgia.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.